BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 106 filers reported holding BICYCLE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,300,600 | -44.0% | 910,930 | -28.9% | 0.01% | -40.0% |
| Q2 2023 | $32,696,892 | +4.3% | 1,281,324 | -13.1% | 0.02% | -4.8% |
| Q1 2023 | $31,363,631 | -29.5% | 1,474,378 | -1.9% | 0.02% | -34.4% |
| Q4 2022 | $44,483,761 | +13.6% | 1,503,447 | -55.3% | 0.03% | +10.3% |
| Q3 2022 | $39,156,117 | +69.8% | 3,361,698 | +144.6% | 0.03% | +81.2% |
| Q2 2022 | $23,066,000 | -69.0% | 1,374,489 | -18.8% | 0.02% | -55.6% |
| Q1 2022 | $74,297,000 | -28.0% | 1,692,774 | -0.2% | 0.04% | -16.3% |
| Q4 2021 | $103,177,000 | +42.2% | 1,695,409 | -2.7% | 0.04% | +34.4% |
| Q3 2021 | $72,557,000 | +29.1% | 1,743,005 | -5.8% | 0.03% | +33.3% |
| Q2 2021 | $56,202,000 | +11.0% | 1,849,720 | +9.2% | 0.02% | +4.3% |
| Q1 2021 | $50,654,000 | – | 1,693,658 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |